Quince Therapeutics Inc (QNCX)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -317.051 | -30.96 | -37.496 | -48.974 | -55.746 | -43.57 | -23.093 |
| Return on Equity (%) | 120.661 | 47.163 | -89.268 | -53.416 | -61.85 | -47.14 | -33.806 |
| Return on Invested Capital (%) | -517.207 | -32.137 | -46.275 | -71.841 | -82.026 | -51.831 | -25.101 |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | -0.923 | 20.932 | 4.298 | 5.831 | 3.943 | 2.62 | 0.088 |
| Earnings Per Share | -3.64 | -3.657 | -1.376 | -2.601 | -2.991 | -1.43 | -0.732 |
| Cash Per Share | 2.185 | 7.29 | 1.906 | 2.262 | 2.318 | 1.234 | 0.484 |
| Working Capital Per Share | 1.718 | 20.846 | 3.616 | 4.091 | 3.24 | 2.509 | 1.583 |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | -3.64 | -3.657 | -1.376 | -2.601 | -2.991 | -1.437 | -0.737 |
| EBITDA Per Share | -3.64 | -3.657 | -1.376 | -2.601 | -2.991 | -1.437 | -0.737 |
| Free Cash Flow Per Share | -3.631 | -3.609 | -1.381 | -2.611 | -2.996 | -1.432 | -0.736 |
| Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 3.36M | 3.41M | 26.87M | 29.54M | 30.07M | 36.14M | N/A |
| Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||
| Shares Outstanding | 36.14M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 81.4M |
| Price to Earnings Ratio | -2.73 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.13 |
| Price to Book Ratio | 1.01 |
| Dividend Yield | - |
| Shares Outstanding | 44M |
| Average Volume (1 week) | 198.79k |
| Average Volume (1 Month) | 286.76k |
| 52 Week Change | 50.41% |
| 52 Week High | 2.45 |
| 52 Week Low | 0.5116 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
